DIAMOND
Prostate Cancer / Posted 4 years ago
DIAMOND: A study looking at biomarkers in prostate, kidney, bladder and testicular cancer
Some people have biomarkers that make them more vulnerable to develop certain types of cancer. In this study, doctors want to look for these biomarkers. They hope this information will help them:
•learn more about the causes of cancer
•develop better tests and treatments
Everyone taking part gives blood, urine, poo and breath samples. Doctors may also ask for a tissue sample if you had, or are going to have, surgery.
The main aim of this study is to look for biomarkers that might play a role in prostate, kidney, bladder and testicular cancer.
Researchers are also looking for men who are going to have a biopsy to find out whether they have prostate cancer. This is part of a sub study called PRIM.
Everyone taking part in the PRIM sub study has a blood test called Prostate Health Index (phi) before having a biopsy.
The main aim of the PRIM sub study is to find out whether the phi test can help doctors diagnose prostate cancer.
-
Inclusion Criteria :
- Who can take part in the main part of this study
- You may be able to join the main part of this study if you have one of the following cancers: prostate, kidney, bladder, testicular.
-
Exclusion Criteria :
- Who can’t take part in the main part of this study
- You cannot join the main part of this study if any of these apply. You: can’t give a sample of semen. have a complete blockage in the tubes that carry urine from each kidney to the bladder (ureter), are taking drugs that have zinc have any medical condition that doctors think could affect you taking part in this study.
- Study start date : 01/03/2003
- Study end date : 28/02/2024
- Wales-Based Study Contact : Not recruiting in Wales
- Principal Investigator : Mr Vincent J. Gnanapragasam